[Cellular calcium signaling in bipolar disorder].

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Context:

• Accurate differential diagnosis between bipolar depression and monopolar depression is critical for effective treatment planning.
• Current diagnostic methods relying solely on symptoms are often insufficient.
• Identifying reliable biological markers for bipolar disorder is a significant clinical need.

Purpose:

• To evaluate the potential of cellular calcium signaling, specifically in human platelets, as a diagnostic biomarker for bipolar disorder.
• To assess the specificity of enhanced calcium responses to serotonin in distinguishing bipolar disorder from other psychiatric conditions.
• To identify limitations and challenges in using platelet calcium signaling as a clinical diagnostic tool.

Summary:

• Abnormalities in cellular calcium signaling, particularly enhanced agonist-stimulated calcium responses in platelets, are a consistent finding in bipolar disorder patients compared to controls.
• Serotonin-induced calcium responses appear specific to bipolar disorder, differentiating it from monopolar depression and other psychiatric diseases.
• Despite promising findings, challenges such as overlapping calcium response distributions, sample handling requirements, medication effects, and the peripheral-central nervous system link hinder immediate clinical application.

Impact:

• Platelet calcium signaling represents a potential, accessible biological marker for bipolar disorder, offering a novel avenue for diagnostic research.
• Understanding these cellular mechanisms may contribute to a deeper understanding of bipolar disorder pathophysiology.
• Further research is needed to overcome existing obstacles before this marker can be reliably integrated into clinical practice for bipolar disorder diagnosis.